Dr. Joseph on Factors Influencing Frontline Therapy Selection in mRCC
Richard W. Joseph, MD, internist and oncologist, Mayo Clinic, discusses considerations for frontline therapy selection in metastatic renal cell carcinoma (mRCC).
Dr. Joseph on Selecting Frontline Therapy in mRCC
Richard W. Joseph, MD, internist and oncologist, Mayo Clinic, discusses the process of selecting frontline therapy in metastatic renal cell carcinoma (mRCC).